Company · CIK 0001594864
Juno Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AJuno Therapeutics, Inc.0001562230-19-000022 · 8.2 KBSEC(opens sec.gov)
- SC 13G/AJuno Therapeutics, Inc.0001072613-18-000203 · 92.9 KBSEC(opens sec.gov)
- SC 13G/AJuno Therapeutics, Inc.0001088875-18-000038 · 10.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-18-071366 · 31.7 KBSEC(opens sec.gov)
- SC 13D/AJuno Therapeutics, Inc.0001144204-18-012682 · 73.0 KBSEC(opens sec.gov)
- SC 13D/AJuno Therapeutics, Inc.0001144204-18-010134 · 61.1 KBSEC(opens sec.gov)
- SC 13D/AJuno Therapeutics, Inc.0001144204-18-009907 · 95.3 KBSEC(opens sec.gov)
- SC 13D/AJuno Therapeutics, Inc.0001144204-18-009074 · 149.4 KBSEC(opens sec.gov)
- SC 13GJuno Therapeutics, Inc.0001562230-18-000031 · 9.0 KBSEC(opens sec.gov)
- SC 13G/AJuno Therapeutics, Inc.0000932471-18-003616 · 45.4 KBSEC(opens sec.gov)
Insiders
- AGARWAL SUNILPresident of R & D
- ARCH Venture Fund VII, L.P.10% Owner
- Azelby RobertEVP & Chief Commercial Officer
- Barron HalDirector
- Bishop Hans EdgarDirector, CEO & President
- Blue Magpie Corp10% Owner
- BRATTON DOUGLAS K10% Owner
- BYBEE CLINTON10% Owner
- Cassidy Bernard JGeneral Counsel & Secretary
- CELGENE CORP /DE/10% Owner
Tickers
No tickers on record.
Addresses
business
400 DEXTER AVENUE NORTH, SUITE 1200
SEATTLE, WA, 98109
mailing
400 DEXTER AVENUE NORTH, SUITE 1200
SEATTLE, WA, 98109
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies